BioLife Solutions Inc
NASDAQ:BLFS
BioLife Solutions Inc
NASDAQ:BLFS
Price:
17.53 USD
3.97%
Market Closed
Updated:
Apr 27, 2024
Section:
Relative Value
The Relative Value of one
BLFS
stock under the Base Case scenario is
12.29
USD.
Compared to the current market price of 17.53 USD,
BioLife Solutions Inc
is
Overvalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BLFS
Relative Value
Base Case
12.29
USD
Overvaluation 30%
Valuation Multiples
Multiples Across Competitors
BLFS Competitors Multiples
BioLife Solutions Inc Competitors
BioLife Solutions Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
791.8m USD | 5.5 | -11.9 | -18 | -14 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.4T JPY | 8.6 | 38.5 | 23.4 | 28.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
35.5B CHF | 4.1 | 40 | 17.8 | 36.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
194.1B DKK | 7.8 | 39.9 | 26.2 | 30.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 6 | 52.1 | 27.8 | 33.8 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
17.7B USD | 4.8 | 60.7 | 22.3 | 37.8 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.3T KRW | 333.3 | -75.6 | -123.3 | -113.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
55.1B CNY | 14 | 33.3 | 29 | 29 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 3.1 | 50.7 | 46.8 | 50.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.3B USD | 1.6 | -48 | 12.2 | 26.3 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 1.3 | -20 | 15.8 | 44.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
